New Fortress Energy LLC (NFE) Completes $400M Share Offering

New Fortress Energy Inc. (Nasdaq: NFE) (“NFE” or the “Company”) announced today that it priced its underwritten public offering of 46,349,942 shares of its Class A common stock, par value $0.01 per share at a public offering price of $8.63 per share.

Wesley R. Edens, chairman of the Board of Directors, the Chief Executive Officer and shareholder of the Company, has agreed to purchase 5,793,742 shares in this offering at the public offering price per share and on the same terms as the other purchasers in this offering. The underwriters will not receive any underwriting discount on these shares as they will on any other shares sold to the public in this offering.

The offering is expected to close on October 2, 2024, subject to customary closing conditions. The Company intends to use the net proceeds from this offering for general corporate purposes.

Morgan Stanley & Co. LLC is acting as joint book-running manager for the offering together with other members of the syndicate.

The offering is being made pursuant to the Company’s effective shelf registration statement filed with the Securities and Exchange Commission (the “SEC”). The offering is being made only by means of a prospectus. Prospective investors should read the prospectus in that registration statement and other documents the Company has filed or will file with the SEC for more complete information about the Company and the offering. You may obtain these documents for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, copies of the prospectus may be obtained from Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014.

This press release does not constitute an offer to sell or the solicitation of an offer to buy shares of common stock, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

You May Also Be Interested In

• Lantern Pharma receives USPTO patent allowance for LP-184 biomarker
• Syntec Optics added to Russell 3000 index
• PodcastOne acquires Billy Corgan podcast distribution rights